Latin America seeks to quadruple its participation in clinical trials

Clinical research is essential to developing new treatment options, improving diagnostic tools, and advancing disease prevention. These efforts not only extend life expectancy and reduce mortality rates but also contribute significantly to the social and economic development of nations. Yet despite its potential, Latin America’s participation in clinical studies remains limited compared with regions such as Europe and the USA.

According to estimates from the Economic Commission for Latin America and the Caribbean (ECLAC), the region faces a range of structural, regulatory and coordination challenges that could be overcome with concerted effort. ECLAC suggests that if these barriers were addressed, the number of clinical studies conducted in Latin America could potentially quadruple.